0000000000725619

AUTHOR

G. Composto

showing 1 related works from this author

Temozolomide (TMZ) in radio-chemotherapy combined schedule for treatment of newly-diagnosed high-grade gliomas (HGG)

2005

1578 Background: Temozolomide (TMZ) is an oral alkylating agent known to cross the blood-brain barrier with efficacy against HGG and a favourable safety profile compared to conventional chemotherap...

OncologyCancer Researchmedicine.medical_specialtyScheduleTemozolomideSettore MED/06 - Oncologia Medicabusiness.industryNewly diagnosedSurgerySafety profileOncologyInternal medicinemedicinebusinessmedicine.drugRadio chemotherapyJournal of Clinical Oncology
researchProduct